Tag Archives: HCI

Best Heal Care Stocks To Watch Right Now

What do Adobe, eBay, and Microsoft all have in common?

Wait, before you answer, let me add a few more names to that list, like Yahoo, Capital One, Uber, Marriott, and Home Depot.

All of these companies have been the target of criminal cyber-attacks. Like cancer, malicious hacking doesnt discriminate it infects organizations large and small, young and old. Attackers have become ever more brazen and sophisticated in their digital assaults on corporate and government entities.

And as my colleague Jimmy Butts pointed out recently, this is (already) leading to a huge opportunity for companies combatting this threat — and for the investors who deploy their money in them.

The Birth (And Growth) Of Cybercrime

This is nothing new, of course. Some of the earliest cyber heists date back to the 1980s when the internet was still in its infancy. But the first major attack in the online era occurred in 2005 when DSW Shoes discovered that the names and credit card numbers of more than a million customers had been pilfered. As things go, that was a small-scale theft.

Best Heal Care Stocks To Watch Right Now: HCI Group, Inc.(HCI)

HCI Group, Inc., through its subsidiaries, provides property and casualty insurance products in Florida. The company provides property and casualty insurance to homeowners, condominium owners, and tenants; and reinsurance. It also leases office or retail space; and owns and operates one full-service restaurant and two marinas. In addition, the company offers Exzeo, a cloud application that provides automation and intelligence across multiple business processes; and Proplet, which enables agents to search property related information, such as wind mitigation reports, inspection reports, claims activity reports, or flood zone areas. Further, it provides Atlas Viewer, a cloud-based data mapping and visualization platform that allows users to upload, view, and share data feeds on a customized map; and provides information technology services. The company was formerly known as Homeowners Choice, Inc. and changed its name to HCI Group, Inc. in May 2013. HCI Group, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    HCI Group Inc (NYSE:HCI)Q42018 Earnings Conference CallMarch 07, 2019, 4:45 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    HCI Group (NYSE:HCI) and National General (NASDAQ:NGHC) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations and profitability.

  • [By Jon C. Ogg]

    HCI Group Inc. (NYSE: HCI), which primarily focuses on the property and casualty insurance business in Florida, was last seen down 1.4% at $40.17. Its 52-week range is $28.70 to $44.25.

Best Heal Care Stocks To Watch Right Now: Enphase Energy, Inc.(ENPH)

Enphase Energy, Inc., incorporated on March 20, 2006, is a provider of energy management solutions. The Company is engaged in designing, developing, manufacturing and selling microinverter systems for the solar photovoltaic (PV) industry. Its semiconductor-based microinverter system converts direct current (DC) electricity to alternating current (AC) electricity at the individual solar module level. The Company offers microinverter systems to the residential and commercial markets in the United States, Canada, the United Kingdom, France, the Benelux region, certain other European markets, Australia and New Zealand.

The Company’s microinverter system consists of three components: Enphase microinverters, an Envoy gateway and Enlighten cloud-based software. The Company’s Enphase microinverters provide power conversion at the individual solar module level by introducing a digital architecture that incorporates custom application specific integrated circuits (ASIC), specialized power electronics devices, and an embedded software subsystem. The Company’s Envoy bi-directional communications gateway is installed at the system location and serves as a hub providing collecting and sending data to Enlighten software, and receiving and distributing microinverter firmware or software updates, thus increasing system availability and providing ongoing utility compliance.

The Company’s Enlighten cloud-based software provides the capabilities to remotely monitor, manage, and maintain an individual system or a fleet of systems. The software collects and analyzes system performance information to enable owners and operators to realize the performance of their solar PV system. The two versions of the monitoring software include MyEnlighten, which is designed for the typical system owner, provides performance assurance, and Enlighten Manager, which is available for the solar professional, provides detailed diagnostic capabilities, as well as fleet management tools.

The Company compet! es with SMA Solar Technology AG, Fronius International GmbH, ABB Ltd. and SolarEdge Technologies, Inc.

Advisors’ Opinion:

  • [By Alex Sirois]

    Renewable Energy Group stock certainly fits that bill. 

    Enphase Energy (ENPH) Source: IgorGolovniov / Shutterstock.com

    A cursory glance at the price chart of Enphase Energy throughout 2021 points, again, to a buy-the-dip opportunity. ENPH stock prices have risen steadily out of a trough in May, going from $114 to $164 currently. Share prices were well above $200 in early 2021. The good news is that ENPH shares are currently riding upward momentum. That momentum should continue based on its July 27 earnings report.

  • [By Tezcan Gecgil]

    The top 10 holdings account for around half of the fund. Among the leading names are the home energy solutions manufacturer Enphase Energy (NASDAQ:ENPH), residential solar systems Sunrun (NASDAQ:RUN), PV Solar solutions First Solar, electric vehicle (EV) leader Tesla (NASDAQ:TSLA), and hydrogen fuel cell solutions developer Plug Power (NASDAQ:PLUG). The market has been paying close attention to many of these names and their product offerings.

Best Heal Care Stocks To Watch Right Now: Hawaiian Holdings, Inc.(HA)

Hawaiian Holdings, Inc., through its subsidiary, Hawaiian Airlines, Inc., engages in the scheduled air transportation of passengers and cargo. It offers daily services on North America routes between the state of Hawaii and Los Angeles, Oakland, Sacramento, San Diego, San Francisco, and San Jose, California; Las Vegas, Nevada; Phoenix, Arizona; Portland, Oregon; and Seattle, Washington, as well as daily services on its neighbor island routes among the four major islands of the state of Hawaii. The company also provides daily services on its international routes between the state of Hawaii and Sydney, Australia; and Tokyo and Osaka, Japan. In addition, it offers scheduled services between the state of Hawaii, and New York City, New York; and scheduled services on its international routes between the State of Hawaii and Pago Pago, American Samoa; Papeete, Tahiti; Brisbane, Australia; Auckland, New Zealand; Sapporo and Sendai, Japan; Seoul, South Korea; and Beijing, China, as well as other ad hoc charter services. Hawaiian Holdings, Inc. markets its tickets through various distribution channels, including its Website hawaiianairlines.com for North America and Neighbor Island route customers, as well as through travel agencies and wholesale distributors for its International routes customers. As of December 31, 2014, the companys fleet consisted of 18 Boeing 717-200 aircraft for the Neighbor Island routes; 10 Boeing 767-300 aircraft; and 19 Airbus A330-200 aircraft for the North America, international, and charter routes, as well as 3 ATR42 turboprop aircraft. Hawaiian Holdings, Inc. was founded in 1929 and is headquartered in Honolulu, Hawaii.

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    One disadvantage for Southwest Airlines is that customers have to bring their own food along. Hawaiian Holdings (NASDAQ:HA) still offers complimentary meals for customers in coach, and other airlines have buy-onboard options. By contrast, Southwest’s planes have small galleys, so the carrier will only offer a “snack bag” on its Hawaii flights. Many travelers may want at least the option of a hot meal for what can be a six-hour flight.

  • [By Adam Levine-Weinberg]

    Shares of Hawaiian Holdings (NASDAQ:HA) cratered on Monday, falling 11% as Southwest Airlines (NYSE:LUV) finally began selling tickets for its long-awaited Hawaii flights. The stock continued to move downward on Tuesday.

  • [By Logan Wallace]

    Hawaiian (NASDAQ:HA) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Wednesday.

Best Heal Care Stocks To Watch Right Now: KBR, Inc.(KBR)

KBR, Inc. (KBR), incorporated on March 21, 2006, is an engineering, procurement, construction and services company. The Company supports global hydrocarbons and international Government services market sectors. The Company offers a portfolio of technology and consulting services; engineering, construction, procurement and asset maintenance services, and base operational, logistics, life support and asset management services. The Company operates through three business segments: Technology & Consulting (T&C), Engineering & Construction (E&C), and Government Services (GS). The Company provides services to a customer base, including international and national oil and gas companies, independent refiners, petrochemical producers, fertilizer producers, manufacturers and domestic and foreign Governments.

T&C

The Company’s T&C segment combines KBR technologies, knowledge-based services and its three specialty consulting brands, Granherne, Energo and GVA, under a single customer-facing global business. This segment provides licensed technologies and consulting services to the oil and gas value chain, from wellhead to crude refining and through to specialty chemicals production. In addition to sharing many of the same customers, these brands deliver a solution to meet the customer’s objectives through planning and scope definition, technologies and project lifecycle support.

The T&C segment offers a spectrum of services and solutions, including licensing, basic engineering and design (BED), proprietary equipment (PEQ), plant automation, catalysts and related consulting services to hydrocarbons, chemicals and fertilizer markets. Services provided by the oil and gas consulting portion of this business include field development and planning, technology selection and optimization of capital spending, offshore integrity management and structural analysis for production platforms in various locations. Services provided by the downstream consulting portion of this business includ! e feasibility and revamp studies, as well as planning activities related to the development and construction of refining, petrochemical, and chemical and fertilizer complexes.

The Company’s T&C segment offers a spectrum of front-end services and solutions, including licensing of technology, basic engineering and design (BED), proprietary equipment (PEQ), plant automation, remote monitoring, catalysts and related specialist consulting services to the hydrocarbons, petrochemicals, chemicals and fertilizer markets. The Company’s front-end upstream industry includes consulting services related to field development planning, technology selection and capital expenditure optimization; plant integrity management; and specialized naval architecture technology (drillships, floating production, storage and offshore (FPSO), and floating production units (FPUs) and structural engineering; feasibility studies, revamp studies, planning/development and construction studies for oil and gas. The Company’s front-end downstream industry includes consulting services related to liquefied natural gas (LNG), refining, petrochemicals, chemicals and fertilizers.

E&C

The Company’s E&C segment offers project delivery solutions from conceptual planning, through FEED and execution planning, to full EPC delivery and ongoing asset services, such as maintenance and turnarounds. E&C provides engineering services and EPC project delivery for the development, construction and commissioning of projects in the offshore and onshore oil and gas industries and LNG/gas-to-liquids (GTL) markets, as well as the refining, petrochemicals, chemicals and fertilizers industries. Its offshore oil and gas services focuses on the hydrocarbons value chain from subsea umbilicals, risers and flowlines (SURF) to fixed and floating platforms, including hulls, moorings and risers (HMR), and onshore oil and gas services across the complete hydrocarbons industry including unconventional oil and gas (UCOG).

GS

!

The Company’s GS segment focuses on service contracts with annuity streams particularly for the United Kingdom, Australian and United States Governments. The Government Services business segment focuses on providing a range of services, including emote life-support services, logistics, program, and risk management services, resilience planning, base operations services, and training for the governments of the United States, United Kingdom and Australia, and other focus countries, across the world. The Company’s service offerings range from construction, refurbishment, operations and maintenance of housing and associated facilities for military personnel to home base and operations support, embassy and critical infrastructure support, life-support programs, heavy equipment transportation, and non-military government facilities management and integration.

The Company competes with Bechtel Corporation, Fluor Corporation, Jacobs Engineering, AECOM, AMEC Foster Wheeler, Chicago Bridge and Iron, Chiyoda Corporation (Chiyoda), JGC Corporation (JGC), McDermott International, Petrofac, Saipem, Technip, John Wood Group PLC and Worley Parsons.

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    KBR Inc (NYSE:KBR)Q42018 Earnings Conference CallFeb. 26, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on KBR (KBR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Watch Right Now: Genesee & Wyoming, Inc.(GWR)

Genesee & Wyoming Inc., incorporated on September 1, 1977, owns and operates over 120 freight railroads across the world, which are organized in approximately 10 regions. The Company operates through three segments, which include North American Operations, Australian Operations and U.K./European Operations. In the United States, the Company has over eight regions, such as Central, Coastal (which includes industrial switching and port operations), Midwest, Mountain West (which includes industrial switching operations), Northeast, Ohio Valley, Pacific and Southern. Outside the United States, the Company has approximately three regions, such as Canada (which includes a contiguous railroad located in the United States), Australia, and U.K./Europe (which consists of operations in Belgium, Germany, the Netherlands, Poland and the United Kingdom).

The Company, through its subsidiaries, provide rail service at over 40 ports in North America, Australia and Europe and perform contract coal loading and railcar switching for industrial customers. Its railroads operate over approximately 15,600 miles of track that is owned, jointly owned or leased by the Company, which includes the Tarcoola to Darwin rail line. It also operates over approximately 5,700 additional miles of track that is owned or leased by others. The Company’s railroads transport a range of commodities, such as agricultural products, chemicals and plastics, metals, metallic ores, coal and coke, minerals and stone, pulp and paper, intermodal, lumber and forest products, petroleum products, food and kindred products, autos and auto spare parts, waste, and other.

North American Operations

The Company’s North American Operations segment includes over nine operating regions that serve approximately 40 the United States and over four Canadian provinces. Its North American Operations segment includes over 110 short line and regional freight railroads with approximately 13,000 track-miles. The Company has approximatel! y 570 freight railroads in the United States operating over 138,400 miles of track. The Company owns and leases over 100 short line railroads and approximately two regional freight railroads in the United States. It operates over eight local (short line) railroads in Canada over approximately 1,500 miles of track.

Australian Operations

The Company’s Australian Operations segment provides rail freight services in South Australia, the Northern Territory and New South Wales. The Australian Operations segment includes the operation of 1,400-mile Tarcoola-to-Darwin rail line, which is the sole north-south rail corridor outside the coasts and primarily carries intermodal and commodity freight. The Company, through its Australian subsidiaries, manages approximately 2,900 miles (approximately 4,700 kilometers) of track in South Australia and the Northern Territory, which includes approximately 1,400 miles (approximately 2,200 kilometers) of track between Darwin and Tarcoola. The Company has over three railroads in Australia. The Australian rail network comprises over three track gauges, such as broad, narrow and standard gauge. There are over three interstate rail segments in Australia, which includes the east-west corridor (Sydney, New South Wales to Perth, Western Australia); the east coast corridor (Brisbane, Queensland to Melbourne, Victoria), and the north-south corridor (Darwin, Northern Territory to Adelaide, South Australia). In addition, there are a number of intrastate rail freight networks servicing agricultural and mining regions in Queensland, New South Wales, Western Australia, South Australia and Victoria.

U.K./European Operations

The Company’s U.K./European Operations segment includes the operations of Freightliner Group Limited (Freightliner). Freightliner is a rail maritime intermodal operator and rail freight company. Its U.K./European Operations segment also includes heavy-haul freight operations in Poland and Germany and cross-border inter! modal ser! vices connecting Northern European seaports with key industrial regions throughout the continent. The Company, through its subsidiaries, owns or leases freight railroads of approximately one in the United Kingdom, over one in Poland and approximately two in the Netherlands. There are approximately 20,000 miles (over 32,000 kilometers) of track owned and managed by the Company and over seven rail operators licensed for freight transport in Great Britain. The German rail network consists of approximately 21,000 miles (over 33,800 kilometers) of track. It has approximately 385 rail operators certified for freight transport in Germany. The Company owns and manages approximately 2,230 miles (over 3,590 kilometers) of track on the Belgian rail network and there are over 10 rail operators licensed for freight transport in Belgium. It has approximately 70 rail operators certified for freight transport in Poland operating over approximately 11,500 miles (over 18,000 kilometers) of track. It owns and manages approximately 4,370 miles (over 7,030 kilometers) of track in Netherlands. It has over 20 rail operators that provide freight rail services in the Netherlands.

Advisors’ Opinion:

  • [By Lou Whiteman]

    Shares of railroad operator Genesee & Wyoming (NYSE:GWR) climbed as much as 9.1% on Monday following reports that the company is exploring strategic options, including a potential sale of a minority stake.

  • [By Stephan Byrd]

    Shares of Genesee & Wyoming Inc (NYSE:GWR) have received an average rating of “Hold” from the thirteen research firms that are presently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, eight have assigned a hold recommendation, two have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $83.63.

Top 10 Medical Stocks To Buy Right Now

The state of Colorado last week reported 2017 revenues generated by taxes, licenses and fees from state-legal sales of marijuana. Total revenues amounted to $247.37 million, an increase of nearly $54 million year over year.

Medical marijuana sales dipped by about 2.3% to $430 million, while recreational sales rose by 30% to $1.07 billion. Total sales rose by 19% year over year to $1.49 billion.

The 2.9% state sales tax generated $30.54 million in revenues, with $11.86 million from medical marijuana sales and $18.68 million from recreational sales. The 2.9% tax on of retail sales of recreational sales expired in June.

The state’s 10% retail sales tax rose from 10% to 15% on July 1, and the annual total generated by this tax was $131.51 million. The 15% retail excise tax generated $71.97 million in revenues for the calendar year. License and fee revenues for 2017 totaled $13.35 million.

Since state-legal sales began in 2014, total sales of marijuana amounted to $4.37 billion and total tax receipts have amounted to $638.98 million, or 14.6% of total sales.

Top 10 Medical Stocks To Buy Right Now: CM Finance Inc(CMFN)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on CM Finance (CMFN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    ValuEngine upgraded shares of CM Finance (NASDAQ:CMFN) from a sell rating to a hold rating in a research note released on Thursday morning.

    Several other analysts have also recently weighed in on CMFN. UBS cut shares of CM Finance from an outperform rating to a market perform rating in a research note on Friday, February 9th. Raymond James cut shares of CM Finance from an outperform rating to a market perform rating in a research note on Friday, February 9th. Redburn Partners cut shares of CM Finance from an outperform rating to a market perform rating in a research note on Friday, February 9th. Finally, Zacks Investment Research cut shares of CM Finance from a hold rating to a sell rating in a research note on Tuesday, April 10th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. CM Finance has a consensus rating of Hold and a consensus price target of $9.75.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on CM Finance (CMFN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Here are some of the news articles that may have impacted Accern Sentiment Analysis’s rankings:

    Get CM Finance alerts:

    CM Finance: This 6.125% Baby Bond Has Begun Trading On The Nasdaq (seekingalpha.com) Critical Contrast: OFS Capital (OFS) & CM Finance (CMFN) (americanbankingnews.com) Earn an 11.3% Yield From This Alternative Bank (incomeinvestors.com) CM Finance Inc (CMFN) Expected to Post Quarterly Sales of $8.64 Million (americanbankingnews.com)

    Shares of CMFN traded up $0.09 during midday trading on Thursday, hitting $8.90. The stock had a trading volume of 20,400 shares, compared to its average volume of 33,742. CM Finance has a 1 year low of $7.40 and a 1 year high of $10.40. The company has a market cap of $120.49 million, a P/E ratio of 7.74 and a beta of 1.20. The company has a current ratio of 0.99, a quick ratio of 0.99 and a debt-to-equity ratio of 0.72.

Top 10 Medical Stocks To Buy Right Now: One Liberty Properties Inc.(OLP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    One Liberty Properties, Inc. (NYSE:OLP) VP Justin Clair sold 3,100 shares of the company’s stock in a transaction dated Monday, May 21st. The stock was sold at an average price of $25.00, for a total value of $77,500.00. Following the completion of the transaction, the vice president now directly owns 32,566 shares in the company, valued at $814,150. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

  • [By Joseph Griffin]

    One Liberty Properties, Inc. (NYSE:OLP) declared a quarterly dividend on Friday, September 14th, Wall Street Journal reports. Shareholders of record on Tuesday, September 25th will be paid a dividend of 0.45 per share by the real estate investment trust on Thursday, October 4th. This represents a $1.80 annualized dividend and a yield of 6.36%. The ex-dividend date is Monday, September 24th.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on One Liberty Properties (OLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on One Liberty Properties (OLP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy Right Now: Vishay Intertechnology, Inc.(VSH)

Advisors’ Opinion:

  • [By Max Byerly]

    Mercury Systems (NASDAQ: MRCY) and Vishay Intertechnology (NYSE:VSH) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.

  • [By Max Byerly]

    Foundry Partners LLC increased its stake in shares of Vishay Intertechnology (NYSE:VSH) by 1.4% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 971,613 shares of the semiconductor company’s stock after purchasing an additional 13,672 shares during the period. Vishay Intertechnology accounts for about 0.8% of Foundry Partners LLC’s holdings, making the stock its 18th biggest position. Foundry Partners LLC’s holdings in Vishay Intertechnology were worth $18,072,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Ethan Ryder]

    Federated Investors Inc. PA reduced its stake in Vishay Intertechnology (NYSE:VSH) by 4.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 911,412 shares of the semiconductor company’s stock after selling 45,465 shares during the quarter. Federated Investors Inc. PA owned about 0.63% of Vishay Intertechnology worth $21,144,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Buy Right Now: Penns Woods Bancorp, Inc.(PWOD)

Advisors’ Opinion:

  • [By Shane Hupp]

    Headlines about Penns Woods Bancorp (NASDAQ:PWOD) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern rates the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Penns Woods Bancorp earned a news impact score of 0.04 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 46.2338385861856 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 10 Medical Stocks To Buy Right Now: S&W Seed Company(SANW)

Advisors’ Opinion:

  • [By Logan Wallace]

    Neuberger Berman Group LLC raised its stake in S&W Seed (NASDAQ:SANW) by 43.6% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 73,415 shares of the company’s stock after purchasing an additional 22,293 shares during the period. Neuberger Berman Group LLC owned 0.30% of S&W Seed worth $264,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on S&W Seed (SANW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on S&w Seed (SANW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Alico (NASDAQ: ALCO) and S&W Seed (NASDAQ:SANW) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, analyst recommendations and risk.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on S&W Seed (SANW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy Right Now: Vaalco Energy Inc(EGY)

Advisors’ Opinion:

  • [By Money Morning News Team]

    And after taking a look at our 10 top penny stocks to watch, we’ll show you a small-cap stock that just signed a deal with Facebook Inc. (Nasdaq: FB)…

    Penny Stock Current Share Price Law Week’s Gain
    Blink Charging Co. (Nasdaq: BLNK) $6.00 288.51%
    Enterprise GP Holdings LP (NYSE: EPE) $2.94 44.00%
    Opko Health Inc. (Nasdaq: OPK) $4.79 43.49%
    MYnd Analytics Inc. (Nasdaq: MYND) $3.15 38.84%
    Arrowhead Pharmaceuticals Inc. (Nasdaq: ARWR) $0.52 37.80%
    Mid-Con Energy Partners LP (Nasdaq: MCEP) $2.08 36.81%
    VAALCO Energy (NYSE: EGY) $1.49 36.04%
    Cel-Sci Corp. (NYSE: CVM) $3.16 35.04%
    WideOpenWest Inc. (NYSE: WOW) $8.41 34.52%
    Legacy Reserves LP (Nasdaq: LGCY) $8.43 33.61%

    While these gains are certainly exciting, it’s important to recognize that investing in penny stocks is also a risky investment strategy.

  • [By Lisa Levin] Gainers
    Cara Therapeutics, Inc. (NASDAQ: CARA) rose 18.2 percent to $13.71 in pre-market trading. Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma entered into ex-U.S. licensing agreement to commercialize KORSUVA™ injection in dialysis patients with pruritus.
    Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 10.6 percent to $2.20 in pre-market trading after surging 12.43 percent on Tuesday.
    VAALCO Energy, Inc. (NYSE: EGY) rose 10.5 percent to $2.37 in pre-market trading after dropping 10.04 percent on Tuesday.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.3 percent to $7.15 in pre-market trading after falling 16.03 percent on Tuesday.
    Tiffany & Co. (NYSE: TIF) rose 7.8 percent to $110.25 in pre-market trading after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance.
    Heat Biologics, Inc. (NASDAQ: HTBX) shares rose 7.1 percent to $2.13 in pre-market trading. after climbing 12.43 percent on Tuesday.
    Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) rose 5.9 percent to $20.01 in pre-market trading after reporting positive Phase 2 Part B data showing treatment with palovarotene significantly reduces new bone growth in patients with FOP.
    Under Armour, Inc. (NYSE: UA) rose 3.5 percent to $18.44 in pre-market trading.
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) shares rose 3.5 percent to $2.95 in pre-market trading.
    MetLife, Inc. (NYSE: MET) rose 3.2 percent to $50.00 in pre-market trading after reporting a $1.5 billion buyback plan.
    Lowe's Companies, Inc. (NYSE: LOW) rose 3.2 percent to $88.51 in pre-market trading. Lowe's reported downbeat results for its first quarter on Wednesday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California.
    AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93.
    TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday.
    Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55.
    VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39.
    Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49.
    Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday.
    Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01.
    MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43.
    World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program.
    Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90.
    NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director.
    Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday.
    Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results.
    21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34.
    Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de
  • [By Joseph Griffin]

    VAALCO Energy, Inc. (NYSE:EGY)’s share price gapped up before the market opened on Wednesday . The stock had previously closed at $2.53, but opened at $2.59. VAALCO Energy shares last traded at $2.75, with a volume of 2086739 shares trading hands.

Top 10 Medical Stocks To Buy Right Now: Kona Grill Inc.(KONA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company reported preliminary first-quarter results. The company said its first quarter revenue rose 286 percent from the same quarter a year ago to $712,000.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 34.5 percent to $4.52 after the company announced it would proceed with Phase 3 development of GR-MD-02 for NASH Cirrhosis following the FDA meeting.
    Boxlight Corporation (NASDAQ: BOXL) shares rose 21.9 percent to $8.1063.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16 percent to $15.65.
    Myomo, Inc. (NYSE: MYO) shares jumped 15.5 percent to $3.6263 after the company disclosed that its application for Medicare codes received favorable preliminary decision.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) rose 13.7 percent to $10.12.
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 13.7 percent to $4.6743.
    Acacia Communications, Inc. (NASDAQ: ACIA) shares gained 12.2 percent to $35.34 as optical sector is seeing strength following President Trump's announcement that he would work with China related to ZTE Corp.
    Tailored Brands, Inc. (NYSE: TLRD) shares rose 11.3 percent to $35.17. Jefferies upgraded Tailored Brands from Hold to Buy.
    Kona Grill, Inc. (NASDAQ: KONA) jumped 10.6 percent to $2.875.
    Federated National Holding Company (NASDAQ: FNHC) shares rose 10.6 percent to $20.29. Raymond James upgraded Federated National Holding from Outperform to Strong Buy.
    Renewable Energy Group, Inc. (NASDAQ: REGI) climbed 10.2 percent to $15.15. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 10.1 percent to $3.16. Stein Mart is expected to release Q1 earnings on May 23.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 9.7 percent to $108.60 after Bloomberg reported that the China’s Commerce Ministry has restar
  • [By Max Byerly]

    Kona Grill (NASDAQ: KONA) and Yum! Brands (NYSE:YUM) are both retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, valuation, dividends and profitability.

  • [By Logan Wallace]

    News stories about Kona Grill (NASDAQ:KONA) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Kona Grill earned a news sentiment score of 0.09 on Accern’s scale. Accern also gave press coverage about the restaurant operator an impact score of 47.6558176409177 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Top 10 Medical Stocks To Buy Right Now: Entree Gold Inc(EGI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Entree Resources (EGI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy Right Now: Astrotech Corporation(ASTC)

Advisors’ Opinion:

  • [By Money Morning Staff Reports]

    After looking at last week’s top performing penny stocks, we’ll show you a small-cap stock with real growth potential that just popped up on our radar…

    Penny Stock Current Share Price Last Week’s Gain
    New Age Beverage Corp. (NADAQ: NBEV) $3.94 286.79%
    India Globalization Capital Inc. (NYSE: IGC) $2.18 181.55%
    Ascent Capital Group Inc. (NASDAQ: ASCMA) $2.16 103.85%
    Netlist Inc. (NASDAQ: NLST) $0.73 80.56%
    Oragenics Inc. (NYSE: OGEN) $0.92 71.63%
    Astrotech Corp. (NASDAQ: ASTC) $3.44 68.37%
    Command Security Corp. (NYSE: MOC) $2.77 51.09%
    Oasmia Pharmaceuticals (NASDAQ: OASM) $3.57 50.66%
    NovaBay Pharmaceuticals Inc. (NYSE: NBY) $2.10 48.15%
    Navidea Biopharmaceuticals Inc. (NYSE: NAVB) $0.25 45.72%

    While the gains these stocks made are exciting, they also highlight the danger of investing in penny stocks.

  • [By Alexander Bird]

    We’re talking 471% potential gains…

    Penny Stock Current Share Price Last Week’s Gain
    Renren Inc. (NYSE: RENN) $2.50 158.64%
    Astrotech Corp. (Nasdaq: ASTC) $4.17 132.80%
    Xenetic Biosciences Inc. (Nasdaq: XBIO) $5.58 71.95%
    Nordic American Tanker Shipping Ltd. (NYSE: NAT) $2.73 38.43%
    United States Antimony Corp. (NYSE: UAMY) $0.49 36.47%
    Soeno Therapeutics Inc. (Nasdaq: SLNO) $2.65 33.05%
    Fibrocell Science Inc. (Nasdaq: FCSC) $3.16 31.36%
    Teekay Tankers Ltd. (NYSE: TNK) $1.30 29.70%
    Neovasc Inc. (Nasdaq: NVCN) $0.04 27.30%
    Actinium Pharmaceuticals Inc. (OTCMKTS: ATNM) $0.24 25.98%

    While the gains of last week’s top penny stocks are exciting, investors who know where to look can unlock even bigger gains…

Top 10 Medical Stocks To Buy Right Now: HCI Group, Inc.(HCI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    HCI Group (NYSE:HCI) and National General (NASDAQ:NGHC) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations and profitability.

  • [By Jon C. Ogg]

    HCI Group Inc. (NYSE: HCI), which primarily focuses on the property and casualty insurance business in Florida, was last seen down 1.4% at $40.17. Its 52-week range is $28.70 to $44.25.

Top Heal Care Stocks To Buy Right Now

Best of Breed

Alaskan Airlines (NYSE:ALK) is the best of breed Airline in the US in terms of how customers view it. In 2016, Alaskan Airlines had an on-time performance track record of 86.05%, higher than all other legacy carriers and only lower than Hawaiian Airlines (NASDAQ:HA) among all domestic airlines. In January, the Wall Street Journal named Alaskan Airlines the best airline in the US for the fourth year in a row. Alaska’s best in breed status becomes even more evident when looking at its financials.

Airline

Op. M

Pr. M

RoA

RoE

ALK

24.50%

13.72%

11.01%

30.47%

Top Heal Care Stocks To Buy Right Now: HCI Group, Inc.(HCI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    HCI Group (NYSE:HCI) and National General (NASDAQ:NGHC) are both finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations and profitability.

  • [By Jon C. Ogg]

    HCI Group Inc. (NYSE: HCI), which primarily focuses on the property and casualty insurance business in Florida, was last seen down 1.4% at $40.17. Its 52-week range is $28.70 to $44.25.

Top Heal Care Stocks To Buy Right Now: Civeo Corporation(CVEO)

Advisors’ Opinion:

  • [By Steve Symington]

    Still, several individual companies easily outran the broader market. Read on to learn why shares of ManTech International (NASDAQ:MANT), Civeo (NYSE:CVEO), and Deutsche Bank (NYSE:DB) each climbed higher today.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Logan Wallace]

    Civeo Corp (NYSE:CVEO)’s share price was up 5.8% during trading on Tuesday . The stock traded as high as $3.53 and last traded at $3.48. Approximately 766,001 shares changed hands during mid-day trading, an increase of 1% from the average daily volume of 754,849 shares. The stock had previously closed at $3.29.

Top Heal Care Stocks To Buy Right Now: NVR Inc.(NVR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    NVR, Inc. (NYSE:NVR) Director Susan Williamson Ross purchased 70 shares of the company’s stock in a transaction on Tuesday, May 15th. The stock was purchased at an average price of $2,995.20 per share, for a total transaction of $209,664.00. Following the purchase, the director now directly owns 64,191 shares of the company’s stock, valued at approximately $192,264,883.20. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Shane Hupp]

    Moneta Group Investment Advisors LLC boosted its holdings in shares of NVR, Inc. (NYSE:NVR) by 102.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 79 shares of the construction company’s stock after acquiring an additional 40 shares during the period. Moneta Group Investment Advisors LLC’s holdings in NVR were worth $235,000 at the end of the most recent reporting period.

  • [By Tyler Crowe]

    It’s very common for a stock to drop when it misses earnings estimates, but NVR’s (NYSE:NVR) 8% stock drop after it beat earnings expectations is quite a rare case. A strange stock move like this raises a lot of questions about what happened with the quarter and what we can expect. 

Top Heal Care Stocks To Buy Right Now: Progenics Pharmaceuticals Inc.(PGNX)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Progenics Pharmaceuticals (PGNX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) shares dropped sharply on Thursday after the company announced late-stage results from its prostate cancer study. Specifically, the firm announced top-line data from its Phase 3 study of 1404, its prostate specific membrane antigen-targeted small molecule SPECT/CT imaging agent that is designed to visualize prostate cancer.

  • [By Cory Renauer]

    Here’s what you need to know about the catalysts that could send these stocks soaring, or plummeting, in the third quarter.

    Company Market Cap Incoming Catalyst
    Spark Therapeutics Inc. (NASDAQ:ONCE)  $3.09 billion Clinical trial results
    Zogenix, Inc. (NASDAQ:ZGNX) $1.56 billion Clinical trial results
    Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) $593 million PDUFA date

    Data source: Yahoo! Finance.

Best Medical Stocks To Own Right Now

With Social Security funding issues around the corner, uncertain market conditions, long-term low interest rates and skyrocketing medical costs, American retirees are facing a laundry list of retirement challenges. The only certainty is that retirement is going to be dramatically different than the retirement previous generations encountered. In order to retire with financial security and dignity, Americans need to make well-informed decisions about when to retire, when to collect Social Security, how to manage their retirement savings and what to do about housing in retirement.  It is this last item, housing in retirement, which often gets the least amount of attention, when in fact, it should be closely scrutinized as a powerful asset.

New research from The American College of Financial Services, The Home Equity and Retirement Income Planning Survey, found that the overwhelming majority, 83 percent of Americans nearing or in retirement, want to remain in their current home for as long as possible. Additionally, the desire to remain in one’s home increased with age. Perhaps somewhat surprisingly, not only did the desire to remain in one’s home increase with age, but the number of years the respondent expected to remain in the home also increased with age. Even if the homeowner needed to relocate later in retirement, almost none of the respondents expressed a desire to rent. This research has also been published in the Journal of Financial Planning – see here.

Best Medical Stocks To Own Right Now: Rockwell Medical Technologies Inc.(RMTI)

Advisors’ Opinion:

  • [By Alex McGuire]

    As a service to our readers, the following list provides the 10 top pharmaceutical stocks to watch this month (May 2017), including the biggest gainers from April…

    Pharmaceutical Stock Current Share Price April 2017 Gain
    Cleveland BioLabs Inc. (Nasdaq: CBLI) $3.62 +120.6%
    Nexvet Biopharma Plc. (Nasdaq: NVET) $6.61 +69.7%
    Motif Bio Plc. (Nasdaq ADR: MTFB) $10.10 +68.2%
    Axovant Sciences Ltd. (NYSE: AXON) $24.43 +62.3%
    Cyclacel Pharmaceuticals Inc. (Nasdaq: CYCC) $5.49 +46.7%
    Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) $8.67 +44.9%
    Akebia Therapeutics Inc. (Nasdaq: AKBA) $13.07 +43.3%
    Akorn Inc. (Nasdaq: AKRX) $33.28 +38.9%
    Rockwell Medical Inc. (Nasdaq: RMTI) $8.78 +37.4%
    Akari Therapeutics Plc. (Nasdaq ADR: AKTX) $15.02 +35.4%

    The best-performing pharma stock of the month – Cleveland BioLabs Inc. – surged 120.6% to $3.53 a share by April 28. That crushed both the Nasdaq Biotech Index’s 1.5% gain and the Dow Jones’ 1.3% rise over the same period.

  • [By Lisa Levin]

    Thursday morning, the healthcare sector proved to be a source of strength for the market. Leading the sector was strength from Keryx Biopharmaceuticals (NASDAQ: KERX) and Rockwell Medical Inc (NASDAQ: RMTI).

Best Medical Stocks To Own Right Now: HCI Group, Inc.(HCI)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap Florida insurance stock HCI Group Inc (NYSE: HCI) has taken a hit with shares down around 21% over the past week on predictions that Hurricane Irma would hit Florida albeit sharesrose 2.74%on Friday when it became clear that it would not be as catastrophic as feared:

Best Medical Stocks To Own Right Now: Sonic Corp.(SONC)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap burger stock Sonic Corporation (NASDAQ: SONC) reported fiscal Q1 2018 earnings after the market closed Thursday that exceeded Wall Street expectations. Total revenues were $105.428 million versus $129.551 million assystem same-store sales declined 1.7% – consisting of a 1.6% same-store sales decrease at franchise drive-ins and a 3.2% decrease at company drive-in. Net income totaled $11.4 million versus net income of $13.1 million. The CEO commented:

  • [By Peter Graham]

    Small cap burger stock Sonic Corporation (NASDAQ: SONC) reported fiscal Q3 2017 earnings after the market closed yesterday with earnings exceeding Wall Street expectations. GAAP revenue was $123.990 million versus $165.239 million as system same-store sales declined 1.2% consisting of a 1.1% same-store sales decrease at franchise drive-ins and a 3.2% decrease at company drive-ins. Net income totaled $18.8 million versus net income of $15.4 million. The Chairman/CEO commented:

  • [By Peter Graham]

    After the market closed yesterday, small cap burger stock Sonic Corporation (NASDAQ: SONC) reported fiscalQ2 2017 earnings with shares falling moderately in after hours trading as the top line missed and the bottom line met expectations. However, it appears analysts are zeroing in on the system same-store sales comps down 7.4% versus expectations for a fall of 4.3%. The decline was comprised of a7.3% same-store sales decline at franchise drive-ins and a decline of 8.9% at company drive-ins.

  • [By Peter Graham]

    A long term performance chart shows shares of newcomers Shake Shack and California based IPO Habit Restaurants both underperforming or below their IPO close prices whilemore established small capburger stocks Red Robin Gourmet Burgers, Inc (NASDAQ: RRGB) and Sonic Corporation (NASDAQ: SONC) were big outperformers up until more recently:

  • [By ]

    Among McDonald’s main rivals, identified by FactSet, are Starbucks Corp. (SBUX) , down almost 5.5%; Yum! Brands (YUM) , which owns KFC, Pizza Hut and Taco Bell, up 32%; and burger chain Sonic Corp. (SONC) , down about 2%. These are all year-over-year percentages.

  • [By Peter Graham]

    A long term performance chart shows shares of small caps Habit Restaurants and Shake Shack Inc (NYSE: SHAK) below their IPO prices while more established burger stocks Red Robin Gourmet Burgers, Inc (NASDAQ: RRGB) and Sonic Corporation (NASDAQ: SONC)have seen their performance drift downward last year or the year before:

Best Medical Stocks To Own Right Now: Sack Lunch Productions (SAKL)

Advisors’ Opinion:

  • [By James E. Brumley]

    Tuesday morning, Sack Lunch Productions Inc (OTCMKTS:SAKL) posted its results for the third quarter (ending September 30th) of the year. They were as strong as you might suspect, with the top line rolling in at $5.35 million, and $142,983 of that turning into net income. That top and bottom line were actually down a bit from the year-ago comparables, though investors should bear in mind that the third quarter of last year was an unusually tough comparison of $6.02 million in sales, and income of $688,845. That was a true breakout quarter for the company’s signature event – Slide the City – and many participants may have come simply to see what it was. The follow-up year (this year), SAKL may not have had the same curiosity factor compelling people to attend.

    Sack Lunch Productions, for the unfamiliar, it’s the name behind event-oriented businesses called Slide the City, Lantern Fest, The Dirty Dash, the Color Me Rad 5K run, and most recently, the Trike Riot. Those are a 1000-foot Slip-n-Slide, a flying lantern release, a mud run, a color-splashing fun run, and a tricycle riding course for kids of all ages and sizes. The events aren’t just fun – they’re FUN!

    They’re also surprisingly profitable. While attendance and per-participant revenue varies, with the average revenue of $30 per participant being at the low end of the scale ( as is the average event attendance of 2500), gross revenue of $75,000 per event is a low-end expectation…

    … not that SAKL hasn’t done some more number crunching of its own. This year, it expects to host roughly 250 events and drive $17 million worth of revenue per event, up about 80% from 2015’s top line. Some of those are being put on by Sack Lunch Productions itself, while others are being hosted by franchisees. Whatever the case, that works out to average revenue of $72,000 per event, with the franchised ones being low-cost to no-cost events for SAKL.

    Regardless, the trend is an impressive one, all

Best Medical Stocks To Own Right Now: Vitality Biopharma (VBIO)

Advisors’ Opinion:

  • [By James E. Brumley]

    Are you an investor interested in learning more about Vitality Biopharma Inc (OTCMKTS:VBIO)? Or, are you looking to take your first look at VBIO? A SeeThruEquity research report posted in August not only has you covered, it underscores all of its hidden bullishness. The report also explains a very impressive target price for Vitality Biopharma shares. In short, the research outfit now believes the stock will see $2.00 per share sooner than later, based on its pipeline and potential market penetration. That’s 38% higher than its current value.

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

  • [By James E. Brumley]

    Investors who were looking to learn a little more about up-and-coming drug development company Vitality Biopharma Inc (OTCMKTS:VBIO) may want to mark December 8th on their calendar…. if they’re going to be in the Los Angeles area that day anyway. The company will be making a presentation that day, at the annual LD Micro Main Event. Interested and approved investors can attend the VBIO presentation by registering beforehand with LD Micro.

    Vitality Biopharma has found a way to make cannabinoid-based pharmaceuticals without the usual downside of cannabinoids. Namely, Vitality Biopharma’s version of cannabinoids are non-psychotropic, meaning larger, more effective dosing is possible without the ‘high’. It’s this little detail that takes cannabinoid medicine — already the most compelling frontier in the world of pharma — to the next level. There’s a reason some people think the cannabinoid market could be worth $20 billion by 2020.

    The idea was significantly advanced in early November. In eight of the nine states voters were asked about legalization of marijuana (for one reason or another), voters said yes….. four for recreational use, and four for medical use. In eight of those nine states, the measures passed. Marijuana is legal in more than half the United States now, and we’re en route to a decided majority in the foreseeable future.

    VBIO didn’t necessarily need a sweeping victory at the ballot box, but each time marijuana wins, it seems to advance the discussion of the power of cannabinoids as medicine.

    Investors will be able to learn more about Vitality Biopharma’s work in that arena on Thursday of this week. On that day — 8 AM PST / 11 AM EST — at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Robert Brooke, CEO of Vitality Biopharma, will be making a presentation as well as meeting with current and prospective investors.

    LD Micro was founded in 2006 with the sole purpose of being an independent resource in t

  • [By James E. Brumley]

    In mid-September, Vitality Biopharma Inc (OTCMKTS:VBIO) announced it was going to take aim at the development of an alternative to opioids as a means of treating pain. At the time, there was little doubt that the company’s cannabinoid science was capable of doing so. What wasn’t clear to VBIO shareholders was exactly how that might happen…. meaning what sort of drug might Vitality Biopharma come up with.

    We got the first of what will likely be several answers to the question today. Per today’s press release, Vitality Biopharma intends to come up with a treatment for narcotic bowel syndrome, which is a severe form of (ironically enough) opiate-induced abdominal pain.

    As a refresher, Vitality Biopharma was the name we introduced to you back on August 8th, pointing out it had developed a whole new way of making cannabinoid-based medicines. Their versions offer all the upsides of cannabinoids, but without the psychotropic (“getting high’) effects, and without some of the common downsides associated with these pharmaceuticals… like mouth and skin lesions.

    There are even bigger advantages to Vitality Biopharma’s science, however. Namely, since these drugs are prodrugs and aren’t activated until in the body, they allow for targeted delivery to the GI tract (yet can also selectively target other body parts, even as far away from the GI tract as the brain). Perhaps more than anything though, these drugs are orally-administered by virtue of being highly soluble, making them easy to use.

    It’s this nuance that makes Vitality Biopharma’s recently-announced intention so interesting, and compelling.

    Studies have found that up to 81% of patients treated with opiates have functional bowel disorders, with more than half — 58% to be exact — of opiate users reporting chronic abdominal pain stemming from the use of their prescribed painkillers. Considering 200 million opioid prescriptions are filled every year in the United States alo

  • [By Matthew Briar]

    Back in September, Vitality Biopharma Inc (OTCMKTS:VBIO) CEO Robert Brooke officially announced his company would be entering the painkiller market, specifically taking aim at the development of an alternative to opioids. His specific words? “Opiates are one of the key classes of drugs we’re seeking to replace, or to make far less necessary, as our proprietary cannabosides could provide a potent alternative form of pain relief and help avoid, or greatly reduce, the use of opiates for the treatment of many conditions…”

Best Medical Stocks To Own Right Now: Ono Pharmaceutical Co., Ltd. (OPHLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Merck could achieve a consistent advantage versus BMS in treatment of 1L NSCLC. There is a precise crossroad that will determine the future of these two companies in this field: the question of whether or not Keytruda will be approved in May. Both the market and investors believe that it will indeed gain approval and BMS’s stock is already paying for that. In the short term, the repercussions will be the contractions in the sales of Opdivo in 2L and a bigger obstacle for Opdivo+Yervoy in 1L. But the BMS’s combo can catch up, thanks to a bigger efficacy, as I will explain in a future article. Meanwhile, a recent trial established that Merck has to pay BMS $625M plus royalties, as it infringed BMS’s intellectual property related to the use of anti-PD1 antibodies. The royalties will be 6.5% for sales between January 2017 and the end of 2023, followed by a 2.5% rate for the period from January 2024 to the end of 2026. Bristol-Myers Squibb will share the money by giving a quarter of the amount to the Japanese Ono Pharmaceutical (OTC:OPHLF), the company which had discovered Opdivo.

stock market analysis software

A high dividend yield can be the ultimate retirement holding. Or it can be a trap.

Today, I’m going to show you five stocks with mouth-watering yields of between 6% and 23% that are tomorrow’s dividend disasters. If you own shares in any of these firms, sell them now.

stock market analysis software: HCI Group, Inc.(HCI)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap Florida insurance stock HCI Group Inc (NYSE: HCI) has taken a hit with shares down around 21% over the past week on predictions that Hurricane Irma would hit Florida albeit sharesrose 2.74%on Friday when it became clear that it would not be as catastrophic as feared:

stock market analysis software: Internationa Flavors & Fragrances, Inc.(IFF)

Advisors’ Opinion:

  • [By Lee Jackson]

    International Flavors & Fragrances Inc. (NYSE: IFF) is yet another company that hit our screens witha 10% institutional owner buying stock twice last week. Winder Investment purchased a total of 70,000 shares. At $128.38per share, the total for the trade was a solid $9 million. Later in the week the company stepped in again and bought another100,000 shares at prices between $129.47 and 132.20 apiece. The total for that buy was posted at $13 million. The shares closed trading last Friday at $133.19, so some timely buys for sure. The 52-week trading range is $112.91 to $143.64. The consensus price target is $131.40.

stock market analysis software: Allscripts Healthcare Solutions, Inc.(MDRX)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Goldman Sachs (NYSE: GS) has at least one billion reasons to hope President Trump’s paring back of Dodd-Frank will include the Volcker Rule: Link

    ECONOMIC DATA
    10:30 a.m. Dallas Fed Manufacturing Business Index
    11:30 a.m. 6-Month Bill Auction
    11:30 a.m. 3-Month Bill Auction
    1 p.m. 2-Year Note Auction
    1:15 p.m. Chicago Fed President Evans Speaks
    6:30 p.m. FOMC Member Kaplan Speaks
    ANALYST RATINGS
    Piper Jaffray upgraded Best Buy Co (NYSE: BBY) from Neutral to Overweight
    Wells Fargo upgraded Allscripts Healthcare (NASDAQ: MDRX) from Market Perform to Outperform
    Mizuho upgraded Universal Health Service (NYSE: UHS) from Neutral to Buy
    Piper Jaffray downgraded The Michaels Companies (NASDAQ: MIK) from Overweight to Neutral
    JMP Securities downgraded KB Home (NYSE: KBH) from Market Outperform to Market Perform
    Raymond James downgraded Sierra Wireless Inc. (NASDAQ: SWIR) from Outperform to Market Perform

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Monica Gerson]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.

    Texas Instruments Incorporated (NASDAQ: TXN) Fri 7/1 62.0 Puts (Wkly) Sweep: 1426 @ ASK $1.24: 1426 traded vs 0 OI: Earnings 7/27 $61.86 Ref
    Allscripts Healthcare Solutions Inc (NASDAQ: MDRX) Jul16 13.0 Puts Sweep: 500 @ ASK $0.45: 500 traded vs 0 OI: Earnings 8/2 $13.07 Ref
    Intel Corporation (NASDAQ: INTC) Jul16 30.0 Puts: 7500 @ ASK $0.26: 7658 traded vs 47k OI: Earnings 7/20 $32.07 Ref
    Ares Capital Corporation (NASDAQ: ARCC) Dec16 16.0 Puts Sweep: 963 @ ASK $2.75: 974 traded vs 18 OI: Earnings 8/2 $14.45 Ref
    LinkedIn Corp (NYSE: LNKD) Aug16 115 Puts: 600 @ ASK $4.05: 615 traded vs 386 OI: $132.12 Ref

    Posted-In: Unusual Put OptionsNews Options Markets

stock market analysis software: American Software, Inc.(AMSWA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of American Software, Inc. (NASDAQ: AMSWA) were down 12 percent to $10.58. American Software reported preliminary Q4 adjusted earnings of $0.09 per share on revenue of $26.3 million.

stock market analysis software: Smith & Nephew SNATS, Inc.(SNN)

Advisors’ Opinion:

  • [By Charles Carlson, CEO and Portfolio Manager, Horizon Investment Services]

    For investors looking for growth but also income, I especially like three health-care related stocksFresenius Medical (FMS), Novo Nordisk (NVO), and Smith & Nephew (SNN).

stock market analysis software: Ono Pharmaceutical Co., Ltd. (OPHLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Merck could achieve a consistent advantage versus BMS in treatment of 1L NSCLC. There is a precise crossroad that will determine the future of these two companies in this field: the question of whether or not Keytruda will be approved in May. Both the market and investors believe that it will indeed gain approval and BMS’s stock is already paying for that. In the short term, the repercussions will be the contractions in the sales of Opdivo in 2L and a bigger obstacle for Opdivo+Yervoy in 1L. But the BMS’s combo can catch up, thanks to a bigger efficacy, as I will explain in a future article. Meanwhile, a recent trial established that Merck has to pay BMS $625M plus royalties, as it infringed BMS’s intellectual property related to the use of anti-PD1 antibodies. The royalties will be 6.5% for sales between January 2017 and the end of 2023, followed by a 2.5% rate for the period from January 2024 to the end of 2026. Bristol-Myers Squibb will share the money by giving a quarter of the amount to the Japanese Ono Pharmaceutical (OTC:OPHLF), the company which had discovered Opdivo.